# MD Start

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/md-start

- Industry: Financial Services
- Headquarters: Paris, France
- Website: www.mdstart.eu
- Total disclosed funding: $11M
- Latest round: Series A (May 2, 2017)
- Investors on record: 4

## About

MD Start SA is a company focused on developing and commercializing innovative medical devices that address critical healthcare challenges, enhancing patient outcomes through advanced technologies.Founded in 2010 and based in Paris, France, MD Start SA specializes in the development of medical devices aimed at improving healthcare delivery. The company has completed a total of 5 deals, with its most recent funding round occurring on January 15, 2021, when it raised EUR 600,000 in Series A funding from Medtronic. The current company valuation stands at EUR 12.124 mn, and the CEO is Thomas Bancel.MD Start specializes in the development and commercialization of innovative medical devices aimed at addressing significant healthcare challenges. Their core offerings focus on advanced diagnostic and therapeutic technologies designed to improve patient outcomes across various medical fields. These products cater to diverse end users, including healthcare providers, hospitals, and patients, primarily in North America and Europe. MD Start collaborates with a portfolio of emerging companies that are actively developing solutions, emphasizing user-centric designs. Their initiatives aim to streamline clinical workflows and enhance treatment effectiveness, making their products essential tools in medical practice.MD Start generates revenue through strategic partnerships and collaborations with healthcare providers and stakeholders in the medical device sector. The company engages in B2B transactions, supplying advanced medical technologies to hospitals and clinics, often through a network of distributors to broaden its market reach. Revenue streams include direct sales of proprietary medical devices and potential licensing agreements. Pricing is based on comprehensive value assessments, highlighting cost-effectiveness and clinical benefits to encourage adoption among healthcare institutions.MD Start is focused on launching new products designed to meet emerging healthcare needs and plans to expand its market presence in North America and Europe through targeted strategies. The recent funding of EUR 600,000 will be utilized to support these initiatives, with an emphasis on enhancing product development and market penetration efforts.

## Funding rounds

- Series A, May 2, 2017, $11M — Sofinnova Partners, Medtronic, Bpifrance, Sorin Group

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- Medtronic — Series A
- Bpifrance — Series A
- Sorin Group — Series A